Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Primo Brands $1.4 billion exchange offers and $3.85 billion financings
The transactions included new notes, the refinancing of a $3.1 billion term loan facility and a new $750 million revolving…
Medical Properties Trust $1.5 billion and €1.0 billion notes offerings
In connection with the issuance of new senior secured notes, the company secured amendments to its credit facilities
Textron $500 million notes offering
The investment-grade notes are due 2035
Air Products and Chemicals €1 billion notes offering
The investment-grade notes are due 2031 and 2037
Central American Bank for Economic Integration £750 million notes offering
The senior notes are due 2028
Mizuho Financial Group $1.9 billion senior notes offering
The offering included fixed-to-fixed reset rate notes and floating-rate notes
BioVersys CHF 80 million IPO and concurrent private placement
We advised AMR Action Fund on its investment in BioVersys
Minera México $1 billion notes offering
The investment-grade notes are due 2032
Morgan Stanley Bank $2.5 billion senior notes offering
We advised Morgan Stanley Bank on its 3(a)(2) notes offering
Morgan Stanley $5.5 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering